Literature DB >> 707179

The mode of mitochondrial degeneration in gliomas.

C S Foster, P E Spoerri, P Glees, O Spoerri.   

Abstract

Morphologically abnormal mitochondria from human glial tumours are described. For each tumour both the appearances of the mitochondria, and the subsequent mode of degeneration and formation of osmiophilic pigment is characteristic. The significance of these observations is discussed, and it is suggested that the mode of degeneration observed reflects directly a fundamental abnormality in composition compared to normal mitochondria.

Entities:  

Mesh:

Year:  1978        PMID: 707179     DOI: 10.1007/bf01587958

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  12 in total

1.  [Cytological research on the normal chondriome or the chondriome subjected to experimentation in living cells cultivated in vitro].

Authors:  J FREDERIC
Journal:  Arch Biol (Liege)       Date:  1958

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Residual bodies and "aging" in cultured human glia cells. Effect of entrance into phase 3 and prolonged periods of confluence.

Authors:  U Brunk; J L Ericsson; J Ponten; B Westermark
Journal:  Exp Cell Res       Date:  1973-04       Impact factor: 3.905

4.  Comparison of the mitochondrial membrane proteins in rat liver and hepatomas.

Authors:  L O Chang; C A Schnaitman; H P Morris
Journal:  Cancer Res       Date:  1971-02       Impact factor: 12.701

5.  [Persistent modification of mitochondria in adenovirus 12-induced hamster tumor cells].

Authors:  W Bernhard; P Tournier
Journal:  Int J Cancer       Date:  1966-01       Impact factor: 7.396

6.  Mitochondrial genesis of lipofuscin in the mesencephalic nucleus of the V nerve of aged rats.

Authors:  G Gopinath; P Glees
Journal:  Acta Anat (Basel)       Date:  1974

Review 7.  Genesis and possible dissolution of neuronal lipofuscin.

Authors:  M Hasan; P Glees
Journal:  Gerontologia       Date:  1972

8.  Neuronal aging in cultures. An electron-microscopic study.

Authors:  P E Spoerri; P Glees
Journal:  Exp Gerontol       Date:  1973-10       Impact factor: 4.032

9.  Cellular membranes and tumor behavior: a new hypothesis.

Authors:  D F Wallach
Journal:  Proc Natl Acad Sci U S A       Date:  1968-11       Impact factor: 11.205

10.  Mitochondrial degeneration after organic phosphate poisoning in prosimian primates.

Authors:  M M Ahmed; P Glees
Journal:  Cell Tissue Res       Date:  1977-01-04       Impact factor: 5.249

View more
  6 in total

1.  Reacting ultrastructure of the human oligodendrocyte (a study of cerebral cortex distant to brain tumours).

Authors:  P E Spoerri; O Spoerri; P Glees
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

2.  Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cells.

Authors:  Corinne E Griguer; Claudia R Oliva; G Yancey Gillespie; Eric Gobin; Pascale Marcorelles; G Yancey Gillespie
Journal:  J Neurooncol       Date:  2006-07-22       Impact factor: 4.130

3.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

4.  Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Jeffrey H Chuang; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2008-08-13       Impact factor: 5.922

Review 5.  Targeting mitochondria as therapeutic strategy for metabolic disorders.

Authors:  Daniela Sorriento; Antonietta Valeria Pascale; Rosa Finelli; Anna Lisa Carillo; Roberto Annunziata; Bruno Trimarco; Guido Iaccarino
Journal:  ScientificWorldJournal       Date:  2014-03-13

Review 6.  Cancer Etiology: A Metabolic Disease Originating from Life's Major Evolutionary Transition?

Authors:  B Poljsak; V Kovac; R Dahmane; T Levec; A Starc
Journal:  Oxid Med Cell Longev       Date:  2019-10-08       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.